Industry Braces For More Pressure On IP For COVID-19 Products
Executive Summary
The controversial “TRIPS waiver” is high on the agenda of the World Trade Organization’s upcoming ministerial conference, while a working group of the World Health Organization is drawing up a draft pandemic treaty that includes proposals to weaken IP on pandemic countermeasures.
You may also be interested in...
Coronavirus Notebook: Moderna Postpones EU Spikevax Supplies, Industry Insists TRIPS Waiver Is Redundant
The medical NGO, MSF, has urged countries not to adopt the latest draft of the proposed waiver, saying it would impair efforts to boost access to COVID-19 products around the world. The WHO has been looking at the benefits of hybrid immunity – and how far it might be waning.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.